Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.35 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.35 |
| ▸ | ITGAL | P20701 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | CRHBP | P24387 | 2/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 2/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29598331 | 1.00 | ABCG2 (0.35) | ABCG2ITGB2ICAM1ITGALGPR84 | |
| SCHEMBL16082355 | 0.90 | HSP90AA1 (0.38) | GPR84HPGDTSHRPKMLMNA | |
| SCHEMBL20086175 | 0.81 | TYMS (0.45) | GPR84HPGDTSHR | |
| SCHEMBL13665385 | 0.76 | MAOA (0.34) | MAOAMAOB | |
| SCHEMBL264532 | 0.76 | MAOA (0.34) | MAOAMAOB | |
| SCHEMBL12316480 | 0.76 | MEN1 (0.31) | — | |
| SCHEMBL4076917 | 0.76 | MAOA (0.34) | MAOAMAOB | |
| SCHEMBL9124665 | 0.73 | ABCG2 (0.36) | ABCG2ITGB2ICAM1ITGALGPR84 | |
| SCHEMBL9120606 | 0.71 | ABCG2 (0.35) | ABCG2ITGB2ICAM1ITGALGPR84 | |
| SCHEMBL12831033 | 0.71 | ABCG2 (0.35) | ABCG2ITGB2ICAM1ITGALGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11932765-B2 | Meltable intumescent flame retardant compositions | QED LABS, INC. (US) | 2024-03-19 | — | — | US | claimed |
| US-20230331986-A1 | MELTABLE INTUMESCENT FLAME RETARDANT COMPOSITIONS | QED LABS INC (US) | 2023-10-19 | — | — | US | claimed |
| CN-102617829-A | Phosphorous-containing flame retardant epoxy waterborne self-emulsifying curing agent and application thereof | CHONGQING RONGJI ENVIRONMENTAL PROT ENGINEERING CO LTD | 2012-08-01 | — | — | CN | claimed |
| EP-2152793-A1 | FLAME RETARDANT COMPOSITIONS | BASF SE (DE) | 2010-02-17 | — | — | EP | claimed |
| WO-2008151986-A1 | FLAME RETARDANT COMPOSITIONS | BASF SE (CH) | 2008-12-18 | — | — | WO | claimed |
| US-11306414-B2 | Articles with improved flame retardancy and/or melt dripping properties | QED LABS INC. (US) | 2022-04-19 | — | — | US | disclosed |
| US-11008458-B2 | Articles with improved flame retardancy and/or melt dripping properties | QED LABS INC. (US) | 2021-05-18 | — | — | US | disclosed |
| US-20190048188-A1 | ARTICLES WITH IMPROVED FLAME RETARDANCY AND/OR MELT DRIPPING PROPERTIES | QED LABS INC. | 2019-02-14 | — | — | US | disclosed |
| US-9931407-B2 | Silicon based drug conjugates and methods of using same | BLINKBIO, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| WO-2017161120-A1 | ARTICLES WITH IMPROVED FLAME RETARDANCY AND/OR MELT DRIPPING PROPERTIES | QED LABS INC. (US) | 2017-09-21 | — | — | WO | disclosed |
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | BLINKBIO, INC. | 2017-07-20 | — | — | US | disclosed |
| US-20160348279-A1 | ARTICLES WITH IMPROVED FLAME RETARDANCY AND/OR MELT DRIPPING PROPERTIES | QED LABS INC. | 2016-12-01 | — | — | US | disclosed |
| US-7365113-B2 | Phosphate ester flame retardants from resorcinol-ketone reaction products | INDSPEC CHEMICAL CORPORATION | 2008-04-29 | — | — | US | disclosed |
| US-7365113-B2 | Phosphate ester flame retardants from resorcinol-ketone reaction products | INDSPEC CHEMICAL CORPORATION | 2008-04-29 | — | — | US | disclosed |
| US-7279515-B2 | Resorcinol carbonate-based phosphate ester compounds as flame retardants | INDSPEC CHEMICAL CORPORATION | 2007-10-09 | — | — | US | disclosed |
| US-7279515-B2 | Resorcinol carbonate-based phosphate ester compounds as flame retardants | INDSPEC CHEMICAL CORPORATION | 2007-10-09 | — | — | US | disclosed |
| EP-1751222-A2 | LOW HEAT RELEASE AND LOW SMOKE REINFORCING FIBER/EPOXY COMPOSITES | Supresta U.S. LLC. (US) | 2007-02-14 | — | — | EP | disclosed |
| EP-1625171-A1 | POLYPHOSPHONATE FLAME RETARDANT CURING AGENT FOR EPOXY RESIN | Supresta LLC (US) | 2006-02-15 | — | — | EP | disclosed |
| WO-2005118276-A2 | LOW HEAT RELEASE AND LOW SMOKE REINFORCING FIBER/EPOXY COMPOSITES | SUPRESTA LLC. (US) | 2005-12-15 | — | — | WO | disclosed |
| WO-2004113411-A1 | POLYPHOSPHONATE FLAME RETARDANT CURING AGENT FOR EPOXY RESIN | SUPRESTA LLC (US) | 2004-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | CD44, MSN, AS3MT | ABCG2 290/4885ITGB2 525/4885ICAM1 756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.